ÂÜÀòÂÒÂ×

Tomas Marsalek serves as the CFO at i&i Biotech Fund since September 2021 and at CEE Specialty s.r.o. since March 2019. Previously, Marsalek held the position of Investment Manager at Royalton Partners from October 2008 to November 2015, with responsibilities that included due diligence, company valuations, financial modeling, business planning, management of portfolio companies, restructuring, and reporting. Marsalek's career also includes experience as a Senior Executive at PricewaterhouseCoopers from June 2004 to October 2008, focusing on due diligence, valuation, and Purchase Price Allocation under IFRS 3 Business Combination. Educational qualifications comprise a Master of Business Administration in Finance from City University of Seattle, a Fellowship of the Association of Chartered Certified Accountants (FCCA), and a Master's degree in Finance from Prague University of Economics and Business.